Total Clarity Wealth Management Inc. Buys Shares of 10,479 Tempus AI, Inc. $TEM

Key Points

• Total Clarity Wealth Management Inc. acquired 10,479 shares of Tempus AI, Inc., valued at approximately $666,000, during the 2nd quarter.
• Several hedge funds, including ARK Investment Management and Vanguard Group, have significantly increased their stakes in Tempus AI, reflecting growing institutional interest.
• Tempus AI reported revenue of $314.64 million for the last quarter, exceeding analyst expectations and reflecting an impressive 89.5% year-over-year growth.

Total Clarity Wealth Management Inc. bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 10,479 shares of the company's stock, valued at approximately $666,000.

Several other hedge funds have also recently made changes to their positions in the company. ARK Investment Management LLC raised its stake in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after buying an additional 1,981,755 shares during the period. Vanguard Group Inc. raised its stake in shares of Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after purchasing an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. raised its stake in shares of Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after purchasing an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the period. Finally, CloudAlpha Capital Management Limited Hong Kong bought a new stake in shares of Tempus AI during the 1st quarter valued at $34,119,000. 24.22% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on TEM shares. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. HC Wainwright boosted their price objective on Tempus AI from $90.00 to $98.00 and gave the company a "buy" rating in a research note on Friday, September 12th. Needham & Company LLC restated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th. BTIG Research boosted their target price on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research report on Wednesday, August 20th. Finally, Bank of America boosted their target price on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $71.83.

Tempus AI Price Performance

TEM opened at $96.39 on Monday. The stock has a 50-day moving average price of $78.89 and a 200-day moving average price of $64.87. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $104.32. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The stock has a market capitalization of $16.75 billion, a P/E ratio of -81.00 and a beta of 4.87.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. During the same period in the prior year, the business earned ($6.86) EPS. The company's revenue for the quarter was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Activity at Tempus AI

In related news, CFO James William Rogers sold 7,528 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the completion of the sale, the chief financial officer directly owned 138,473 shares in the company, valued at $10,337,009.45. This represents a 5.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Ryan Fukushima sold 5,000 shares of the stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $92.32, for a total value of $461,600.00. Following the sale, the chief operating officer owned 130,000 shares of the company's stock, valued at $12,001,600. This represents a 3.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 933,662 shares of company stock worth $68,070,993 over the last three months. Corporate insiders own 26.27% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.